Possible mechanism by which somatostatin-induced glucagon suppression improves glucose tolerance during insulinopaenia in man

Diabetologia

Volumn 17, Issue 3, 1979, Pages 139-143

  Liljenquist, J E ^a   Bloomgarden, Z T ^a   Cherrington, A D ^a   Perry, J M ^a   Rabin, D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glucagon; hepatic vein catheterization; hyperglycaemia; insulin; net splanchnic glucose production; somatostatin

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN; SOMATOSTATIN;

ADOLESCENT; ADULT; DOSE LIVER FUNCTION RELATION; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOREACTIVITY; INTRAVENOUS DRUG ADMINISTRATION; LIVER; LIVER BLOOD FLOW; LIVER VEIN; NORMAL HUMAN; PERIPHERAL VASCULAR SYSTEM; SPECTROPHOTOMETRY; THEORETICAL STUDY; VEIN CATHETERIZATION;

ADOLESCENT; ADULT; GLUCAGON; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INSULIN; MALE; SOMATOSTATIN;

EID: 0018719064     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/BF01219739     Document Type: Article

References (29)

1. Effects of somatostatin on plasma glucose and glucagon levels in human diabetics mellitus. Pathophysiologic and therapeutic implications
2. Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus
3. Hyperglucagonemia and its suppression
4. Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man
5. Metabolism of forearm tissues in man. Studies with glucagon
6. Gluconeogenesis from alanine in normal postabsorptive man. Intrahepatic stimulatory effect of glucagon
7. Manual feedback technique for control of blood glucose concentration
8. Estimation of hepatic blood flow with indocyanine green
9. Hepatic vascular bed
10. Solid phase synthesis of somatostatin and glucagon-selective analogs in gram quantities
11. Importance of the hematocrit in interpretation of blood sugar
12. Pancreatic glucagon secretion in normal and diabetic subjects
13. Radioimmunoassay of proteins with the use of Sephadex-coupled antibodies
14. Glucagon physiology
15. The control of glycogen metabolism in the liver
16. Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon
17. Hyperglucagonemia and blood glucose regulation in normal, obese, and diabetic subjects
18. Pancreatectomized man: a model for diabetes without glucagon
19. The effect of glucose and of potassium ions on the interconversion of the two forms of glycogen phosphorylase and of glycogen synthetase in isolated rat liver preparations
20. Effects of diabetes on glucose regulation of enzymes involved in hepatic glycogen metabolism
21. Serum insulin levels following administration of exogenous insulin
22. Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose balance
23. Effects of exogenous hyperglucagonemia in insulin-treated diabetics
24. Clinical evaluation of somatostatin as a potential adjunct to insulin in the management of diabetes mellitus
25. 24-hour studies of the effects of somatostatin on the levels of plasma growth hormone, glucagon, and glucose in normal subjects and juvenile diabetics
26. Metabolic effects of somatostatin in maturity-onset diabetes
27. Somatostatin in maturity-onset diabetes